Agenda

The Event

In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 40 speakers will present a full conference programme covering the topics outlined below.

VP and Director Panel Discussion Topics – Day 1

  • PANEL 1: Will Asia “Produce” in Regards to Drug Development
  • PANEL 2: Regulatory updates for Registration for Multinational Clinical Trials – China, Japan, South Korea & Singapore
  • PANEL 3: Innovation Strategies to Advance R&D in Asia
  • PANEL 4: CRO – R&D Collaborations and Business Models

5th Annual Pharma R&D World Asia Congress

Day 1 – Innovation Strategies to Advance R&D in Asia

  • R&D collaborations between East & West
  • Guaranteeing successful outsourcing partnerships
  • Successful business models in CRO partnership
  • Multi-national pharma companies in emerging markets
  • International regulatory updates including FDA breakthrough regulation, EMA RMP regulation

Day 2 – Drug Innovation and Drug Development Activities in Asia

  • Translational research strategies: discovery to development
  • Regulatory considerations for multiregional drug approval
  • Targeted Therapy & Molecular Targeted Drugs
  • Developing companion diagnostics for Targeted Therapies
  • Drug development in oncology and other therapeutic areas
  • Novel methods to accelerate drug development pipeline
  • In licensing strategies

4th  Annual Clinical Development and Outsourcing Asia Congress

Day 1– Clinical Development Activities & Clinical Outsourcing Strategies

  • Regional clinical development  activities in Asia and Asia Pacific regions – China, Japan, South Korea & Singapore
  • Clinical development activities in oncology and other therapeutic areas
  • Selecting the correct Pharma – CRO partnership for maximum success
  • Changing regulatory environment in China and impact of this on multinational drug development activities
  • Regulatory updates for Registration for Multinational Clinical Trials – China, Japan, South Korea & Singapore

Day 1 – Featured Technology Stream – Enabling Technologies for Clinical Development and Personalised Medicine

  • Imaging biomarkers: bridging preclinical and clinical research
  • Medical Imaging technologies
  • Implementing biomarkers in early phase clinical trials
  • Development of  Companion Diagnostics in Clinical Trials
  • Biometrics in Asia Pacific Clinical Trials

Day 2 – Clinical Trials Management Strategies in Asia and Asia Pacific Regions

  • Implementing successful patient recruitment and retention strategies
  • Opportunities of bridging studies in Asia for Global Development
  • Country and site selection for global clinical trials
  • Overcoming regulatory hurdles in Asia and Asia Pacific regions
  • Managing clinical trials in oncology and other therapeutic areas
  • Ensuring pharmacovigilance and patient safety in clinical trials in Asia
  • Clinical supply chain management
  • Managing Safety and Efficacy
deltestimonialclinpharmaasia2014_msddeltestimonialclinpharmaasia2014_rochedeltestimonialclinpharmaasia2014_shenogendeltestimonialclinpharmaasia2014_md-anderson-cancer-centredeltestimonialclinpharmaasia2014_bayer-healthcaredeltestimonialclinpharmaasia2014_eli-lillytestimonials_01deltestimonialclinpharmaasia2014_novonordisk